Biomimetic aminoated mesoporous silica xerogel exhibiting chiral surface topology for delivery insoluble drug with multiple-controlled manners and improved oral adsorption
Source abstract
Abstract
Driven by the clinical demand on improving the oral bioavailability and reducing the side effects of insoluble drug, aminoated mesoporous silica xerogel (named L/d-BPEIN-MSX) with chiral surface topology was constructed through a facile, economical, and biomimetic strategy within 2 min, and served as the carrier of indomethacin (IMC). In the synthetic process, L/d-tartaric acid (L/d-TA) self-assembled with branched polyethyleneimine (BPEI) to endow chirality and synergistic promoted silica deposition, while 3-aminopropyl triethoxysilane (APTES) polycondensated with the silica source to form aminoated mesostructure. By premixed strategy, IMC can be in situ loaded into L/d-BPEIN-MSX with high efficiency, which then became active in circular dichroism (CD) spectra owing to induced chirality. Noteworthy, IMC-L/d-BPEIN-MSX significantly improved the release rate of IMC with multiple controlled release manners. That is, d-BPEIN-MSX had favorable drug release behavior which could respond to the chiral stimuli, whereas l-BPEIN-MSX exhibited advantageous chiral surface topology that was beneficial for bio-processes related to oral adsorption. Undoubtedly, they increased the bioavailability of IMC to 8–9 times, displayed good anti-inflammatory effect, and reduced the gastrointestinal irritation of IMC. In addition, L/d-BPEIN-MSX had low toxicity and irritation, and was proven to be biodegradable and biocompatible, which could meet the requirement for biomedical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Layered Double Hydroxides Synthesis and Applications · Diatoms and Algae Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Development of solid SEDDS, VII: Effect of pore size of silica on drug release from adsorbed self-emulsifying lipid-based formulations10.1016/j.ejps.2017.05.014 ↗
2. Perspective on drug delivery in 205010.1016/j.jconrel.2022.02.025 ↗
3. Impact of particle size and pH on protein corona formation of solid lipid nanoparticles: a proof-of-concept study10.1016/j.apsb.2020.10.023 ↗
4. Poorly water-soluble drug nanoparticles via an emulsion-freeze-drying approach10.1016/j.jcis.2011.01.056 ↗
5. Compartmentalized and Internally Structured Particles for Drug Delivery-A Review10.2174/1381612811319350007 ↗
6. The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin10.1016/j.apsb.2021.02.015 ↗
7. Amorphous calcium (ortho) phosphates10.1016/j.actbio.2010.06.031 ↗
8. Amorphous Drug-Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Case of Clofazimine and Poly(acrylic acid)10.1021/acs.molpharmaceut.0c01180 ↗
9. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour10.1016/j.ejpb.2015.07.003 ↗
10. Mesoporous silica nanoparticles as carriers of active agents for smart anticorrosion organic coatings: a critical review10.1039/D1NR01899J ↗
11. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery10.1080/17425247.2019.1575806 ↗
12. Loading of an anti-cancer drug into mesoporous silica nano-channels and its subsequent release to DNA10.1039/C6NR06285G ↗
13. Multifunctional mesoporous silica nanoparticles for pH-response and photothermy enhanced osteosarcoma therapy10.1016/j.colsurfb.2022.112615 ↗
14. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin10.1016/j.colsurfb.2017.03.024 ↗
15. Polydopamine doped reduced graphene oxide/mesoporous silica nanosheets for chemo-photothermal and enhanced photothermal therapy10.1016/j.msec.2018.10.093 ↗
16. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor10.1016/j.colsurfb.2020.110941 ↗
17. Construction of nanoceria-capped mesoporous silica carriers for redox/pH-responsive drug release10.1016/j.jddst.2021.102763 ↗
18. FA-BSA gated redox-triggered hollow mesoporous silica hybrid nanocapsule delivery system10.1016/j.micromeso.2021.111033 ↗
19. Superiority of Chiral-handed mesoporous silica nanoparticles in delivering Nimesulide10.1016/j.mseb.2021.115161 ↗
20. Functional mesoporous silica nanoparticles for delivering nimesulide with chiral recognition performance10.1016/j.micromeso.2019.109862 ↗
21. Emerging Chirality in Nanoscience10.1039/C2CS35332F ↗
22. Chiral surfaces: The many faces of chiral recognition10.1016/j.cocis.2017.10.004 ↗
23. The Development of Chiral Nematic Mesoporous Materials10.1021/ar400243m ↗
24. Chiral mesoporous silica: chiral construction and imprinting via cooperative self-assembly of amphiphiles and silica precursors10.1039/C0CS00002G ↗
25. The DNA double helix fifty years on10.1016/j.compbiolchem.2003.08.001 ↗
26. Chiral self-assembly of nanoparticles induced by polymers synthesized via reversible addition-fragmentation chain transfer polymerization
27. Chiral mesoporous silica nano-screws as an efficient biomimetic oral drug delivery platform through multiple topological mechanisms10.1016/j.apsb.2021.08.014 ↗
28. Synthesis, structural properties, biosafety and applications of chiral mesoporous silica nanostructures10.1016/j.cej.2020.127862 ↗
29. Concealed body mesoporous silica nanoparticles for orally delivering indometacin with chiral recognition function10.1016/j.msec.2018.04.071 ↗
30. High-temperature-resistant chiral silica generated on chiral crystalline templates at neutral ph and ambient conditions†10.1002/anie.201108914 ↗
31. Effect of trehalose on structural state of bovine serum albumin adsorbed onto mesoporous silica and the protein release kinetics in vitro10.1016/j.colsurfa.2017.05.014 ↗
32. Facile synthesis of functionalized ionic surfactant templated mesoporous silica for incorporation of poorly water-soluble drug10.1016/j.ijpharm.2015.07.014 ↗
33. Multimodal nanoporous silica nanoparticles functionalized with aminopropyl groups for improving loading and controlled release of doxorubicin hydrochloride10.1016/j.msec.2017.04.060 ↗
34. Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies10.1016/j.apsb.2021.03.007 ↗
35. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity10.1021/nn2013904 ↗